Goodbye, morning sickness; hello, legal action
Kim Kardashian is no stranger to Instagram promotion, but a recent post has landed her in hot water with an unexpected enemy: the Food and Drug Administration. In a letter dated August 7th, the FDA's Office of Prescription Drug Promotion requested that Kardashian take down a post promoting Diclegis, a drug that combats morning sickness. The office reviewed Kardashian's post in response to a complaint about its validity and found that it was "false and misleading... it omits material facts." Kardashian posted her bit of promotion at the end of July. It's since been removed from Instagram, but you can see it below thanks to a screencap from Forbes:/cdn0.vox-cdn.com/uploads/chorus_asset/file/3960422/Kim-Kardashian-West-Instagram-Diclegis-copy-cropped.0.jpg)
/cdn0.vox-cdn.com/uploads/chorus_asset/file/3960422/Kim-Kardashian-West-Instagram-Diclegis-copy-cropped.0.jpg)
Forbes / Kim Kardashian / Instagram
KARDASHIAN MAY NEED TO POST A PHOTOGRAPHIC MEA CULPA
In order to right its wrongs, Duchesnay probably needs to enlist Kardashian's help. The company has to respond in writing to the FDA's letter by August 21st, confirming that it'll comply with the agency's request. (According to The Washington Post, Duchesnay is already proceeding with a response.) More importantly, it has to "disseminate truthful, non-misleading, and complete corrective messages about the issues discussed in this letter to the audience(s) that received the violative promotional materials." The FDA is making this request because of Duchesnay's pattern of bad behavior.
What does this mean for Kardashian? If the government has its way, she'll be posting a photographic mea culpa sometime soon: "To the extent possible, corrective messaging should be distributed using the same media, and generally for the same duration of time and with the same frequency that the violative promotional material was disseminated."
0 comments:
Post a Comment